|
Status |
Public on Jul 02, 2020 |
Title |
Combined Inhibition of JAK/STAT Pathway and Lysine Demethylase 1 as a Novel Therapeutic Strategy in CSF3R/CEBPA Mutant Acute Myeloid Leukemia |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
32471953 |
|
Submission date |
Oct 03, 2019 |
Last update date |
Jul 02, 2020 |
Contact name |
Theodore Paul Braun |
E-mail(s) |
[email protected]
|
Organization name |
OHSU
|
Department |
Knight Cancer Institute
|
Lab |
3181 SW Sam Jackson Park Road
|
Street address |
3181 SW Sam Jackson Park Road
|
City |
Portland |
State/province |
OR |
ZIP/Postal code |
97239 |
Country |
USA |
|
|
Platforms (2) |
|
Samples (25)
|
GSM4106420 |
RNA-seq on DMSO treated murine leukemia cells 1 |
GSM4106421 |
RNA-seq on DMSO treated murine leukemia cells 2 |
GSM4106422 |
RNA-seq on DMSO treated murine leukemia cells 3 |
GSM4106423 |
RNA-seq on GSKLSD1 treated murine leukemia cells 1 |
GSM4106424 |
RNA-seq on GSKLSD1 treated murine leukemia cells 2 |
GSM4106425 |
RNA-seq on GSKLSD1 treated murine leukemia cells 3 |
GSM4106432 |
RNA-seq on DMSO treated murine leukemia cells-1 |
GSM4106433 |
RNA-seq on DMSO treated murine leukemia cells-2 |
GSM4106434 |
RNA-seq on DMSO treated murine leukemia cells-3 |
GSM4106435 |
RNA-seq on ruxolitinib treated murine leukemia cells-1 |
GSM4106436 |
RNA-seq on ruxolitinib treated murine leukemia cells-2 |
GSM4106437 |
RNA-seq on ruxolitinib treated murine leukemia cells-3 |
GSM4106438 |
RNA-seq on GSKLSD1 treated murine leukemia cells-1 |
GSM4106439 |
RNA-seq on GSKLSD1 treated murine leukemia cells-2 |
GSM4106440 |
RNA-seq on GSKLSD1 treated murine leukemia cells-3 |
GSM4106441 |
RNA-seq on ruxolitinb+GSKLSD1 treated murine leukemia cells-1 |
GSM4106442 |
RNA-seq on ruxolitinb+GSKLSD1 treated murine leukemia cells-2 |
GSM4106443 |
RNA-seq on ruxolitinb+GSKLSD1 treated murine leukemia cells-3 |
GSM4106444 |
DMSO-H3K4me1 |
GSM4106445 |
DMSO-H3K4me3 |
GSM4106446 |
DMSO-H3K27Ac |
GSM4106447 |
GSKLSD1-H3K4me1 |
GSM4106448 |
GSKLSD1-H3K4me3 |
GSM4106449 |
GSKLSD1-H3K27Ac |
GSM4106450 |
Input |
|
This SuperSeries is composed of the following SubSeries: |
GSE138384 |
Combined Inhibition of JAK/STAT Pathway and Lysine Demethylase 1 as a Novel Therapeutic Strategy in CSF3R/CEBPA Mutant Acute Myeloid Leukemia [LSD1i RNA-seq] |
GSE138386 |
Combined Inhibition of JAK/STAT Pathway and Lysine Demethylase 1 as a Novel Therapeutic Strategy in CSF3R/CEBPA Mutant Acute Myeloid Leukemia [RUX_GSK RNA-seq] |
GSE138387 |
Combined Inhibition of JAK/STAT Pathway and Lysine Demethylase 1 as a Novel Therapeutic Strategy in CSF3R/CEBPA Mutant Acute Myeloid Leukemia [LSD1i ChIP-seq] |
|
Relations |
BioProject |
PRJNA575722 |